InsidersTradesSigma
Follow the JW (Cayman) Therapeutics Co. Ltd - B stock price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares are quoted on the HK market, under the authority of HKEX. Market capitalisation: €84.2m. The latest transaction was disclosed on 28 July 2026 (Purchase). Among the most active insiders: TIAN FENG. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
JW (Cayman) Therapeutics Co. Ltd - B is a company focused on developing innovative therapies. It concentrates on treatments for serious diseases and unmet medical conditions.